MDT

82.86

-5.69%↓

VEEV

213.67

-3.6%↓

A

100.51

-8.39%↓

HQY

76.5

-7.7%↓

PDCO

30.94

-0.83%↓

MDT

82.86

-5.69%↓

VEEV

213.67

-3.6%↓

A

100.51

-8.39%↓

HQY

76.5

-7.7%↓

PDCO

30.94

-0.83%↓

MDT

82.86

-5.69%↓

VEEV

213.67

-3.6%↓

A

100.51

-8.39%↓

HQY

76.5

-7.7%↓

PDCO

30.94

-0.83%↓

MDT

82.86

-5.69%↓

VEEV

213.67

-3.6%↓

A

100.51

-8.39%↓

HQY

76.5

-7.7%↓

PDCO

30.94

-0.83%↓

MDT

82.86

-5.69%↓

VEEV

213.67

-3.6%↓

A

100.51

-8.39%↓

HQY

76.5

-7.7%↓

PDCO

30.94

-0.83%↓

Search

Repligen Corp

Slēgts

SektorsVeselības aprūpe

111.88 -8.01

Pārskats

Akcijas cenas izmaiņa

24h

Šī brīža

Min

106.78

Max

121.6

Galvenie mērījumi

By Trading Economics

Ienākumi

-33M

-34M

Pārdošana

13M

168M

P/E

Sektora vidējais

466.89

63.778

EPS

0.44

Peļņas marža

-20.215

Darbinieki

1,778

EBITDA

12M

34M

Rekomendācijas

By TipRanks

Rekomendācijas

Pirkt

Prognoze 12 mēnešiem

+56.57% upside

Dividendes

By Dow Jones

Nākamie ieņēmumi

2025. g. 30. apr.

Tirgus statistika

By TradingEconomics

Tirgus kapitalizācija

-1.8B

7.5B

Iepriekšējā atvēršanas cena

119.89

Iepriekšējā slēgšanas cena

111.88

Ziņu noskaņojums

By Acuity

13%

87%

14 / 386 Rangs Healthcare

Tehniskais rādītājs

By Trading Central

Pārliecība

Bearish Evidence

Repligen Corp Grafiks

Pagātnes rezultāti nav uzticams nākotnes rezultātu rādītājs.

Saistītās ziņas

2025. g. 4. apr. 22:38 UTC

Karstas akcijas

Stocks to Watch: Eli Lilly, Novo Nordisk, Hims & Hers, Maxeon Solar Technologies

2025. g. 4. apr. 21:53 UTC

Tirgus saruna

Maxeon's Supply Chain Move at Critical Time for Solar Panel Cos -- Market Talk

2025. g. 4. apr. 21:44 UTC

Top Ziņas
Iegādes, apvienošanās, pārņemšana

Trump Grants 75-Day Extension to Reach TikTok Deal -- 3rd Update

2025. g. 4. apr. 21:00 UTC

Top Ziņas

Americans Were Souring on Trump's Economic Plans Even Before Tariff Bloodbath -- WSJ

2025. g. 4. apr. 20:52 UTC

Tirgus saruna

Peloton Likely to Escape Tariffs Unscathed -- Market Talk

2025. g. 4. apr. 20:52 UTC

Top Ziņas

Trump Can Cut Teacher-Training Programs For Now, Supreme Court Says -- WSJ

2025. g. 4. apr. 20:50 UTC

Tirgus saruna

Basic Materials Roundup: Market Talk

2025. g. 4. apr. 20:48 UTC

Top Ziņas

The Score: Nike, Apple, Stellantis and More Stocks That Defined the Week -- WSJ

2025. g. 4. apr. 20:45 UTC

Top Ziņas

Hiring Defied Expectations in March, With 228,000 New Jobs -- 6th Update

2025. g. 4. apr. 20:32 UTC

Top Ziņas

Dow Tumbles 2,000 Points, Bonds Rally After China Retaliates Against Trump Tariffs -- WSJ

2025. g. 4. apr. 20:21 UTC

Top Ziņas

China Hits Back at Trump With Sweeping Tariffs on All U.S. Goods -- Update

2025. g. 4. apr. 20:00 UTC

Top Ziņas

Republicans March Ahead on Trump's Tax Cuts as Tariffs Kick In -- WSJ

2025. g. 4. apr. 19:51 UTC

Tirgus saruna

Dollar Recovers While Recession Fears Grip Wall Street -- Market Talk

2025. g. 4. apr. 19:37 UTC

Top Ziņas

Trump's Team is Getting the Bond Rally It Wanted. But for the Wrong Reasons. -- WSJ

2025. g. 4. apr. 19:32 UTC

Tirgus saruna

Oil Selloff Continues as China Responds to U.S. Tariffs -- Market Talk

2025. g. 4. apr. 19:28 UTC

Top Ziņas

U.S. Stocks Fall Further After China Retaliates Against Trump Tariffs -- Update

2025. g. 4. apr. 19:15 UTC

Tirgus saruna

Costco Gold, Membership Fees Could Help Cushion from Tariff Costs -- Market Talk

2025. g. 4. apr. 19:12 UTC

Top Ziņas

Powell Warns of Higher Prices, Weaker Growth After Tariff Plan -- 3rd Update

2025. g. 4. apr. 19:11 UTC

Tirgus saruna

U.S. Natural Gas Falls as Global Selloff Continues -- Market Talk

2025. g. 4. apr. 19:09 UTC

Tirgus saruna

Mexican Stocks, Peso Tumble as Global Rout Continues -- Market Talk

2025. g. 4. apr. 19:09 UTC

Top Ziņas

Trump Grants 75-Day Extension to Reach TikTok Deal -- Second Update

2025. g. 4. apr. 19:00 UTC

Tirgus saruna

Fed Has Limited Options to Counter Tariffs -- Market Talk

2025. g. 4. apr. 18:53 UTC

Tirgus saruna

Brace for Trump's Tariff Order to Remain in Place for Extended Period -- Market Talk

2025. g. 4. apr. 18:51 UTC

Tirgus saruna

Morgan Stanley Analysts Outline Paths to Recession -- Market Talk

2025. g. 4. apr. 18:44 UTC

Tirgus saruna

Market Talk Roundup: Latest on U.S. Politics

2025. g. 4. apr. 18:44 UTC

Tirgus saruna

Global Forex and Fixed Income Roundup: Market Talk

2025. g. 4. apr. 18:44 UTC

Tirgus saruna

Tariffs Won't Achieve What Trump Wants, Morgan Stanley Says -- Market Talk

2025. g. 4. apr. 18:43 UTC

Iegādes, apvienošanās, pārņemšana

Trump Extends Deadline for TikTok Ban Another 75 Days. ByteDance Says 'An Agreement Has Not Been Executed.' -- Barrons.com

2025. g. 4. apr. 18:43 UTC

Iegādes, apvienošanās, pārņemšana

Trump Extends TikTok Ban Deadline A Second Time As Deal Chatter Swirls -- IBD

2025. g. 4. apr. 18:39 UTC

Tirgus saruna

Protectionism is Back, And Recession Could Follow, Morgan Stanley Says -- Market Talk

Salīdzinājums

Cenas izmaiņa

Repligen Corp Prognoze

Cenas mērķis

By TipRanks

56.57% augšup

Prognoze 12 mēnešiem

Vidējais 190.55 USD  56.57%

Augstākais 220 USD

Zemākais 155 USD

Pamatojoties uz 15 Volstrītas analītiķiem, kuri piedāvā 12 mēnešu cenu mērķi Repligen Corp — pēdējo 3 mēnešu laikā.

Vērtējuma vienprātība

By TipRanks

Pirkt

15 ratings

10

Pirkt

5

Turēt

0

Pārdot

Tehniskais rādītājs

By Trading Central

N/A / 124.84Atbalsts un pretestība

Īstermiņā

Bearish Evidence

Vidējā termiņā

Strong Bearish Evidence

Ilgtermiņā

Bearish Evidence

Noskaņojums

By Acuity

14 / 386 Rangs Veselības aprūpe

Ziņu noskaņojums

Ļoti spēcīga liecība "buļļu" tendencei

Volatilitāte

Zem vidējā

Ziņu apjoms (RCV)

Zem vidējā

Finanšu rādītāji

Pārdošanas un administrēšanas izmaksas

Darbības izmaksas

Peļņa pirms nodokļu nomaksas

Pārdošana

Pārdošanas maksa

Bruto peļņa no pārdošanas

Procentu izdevumi par parādu

EBITDA

Pamatdarbības peļņa

$

Par Repligen Corp

Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products. The company's chromatography products include OPUS pre-packed chromatography columns, which are used in the purification of biologics; and OPUS smaller-scale columns that are used in the high throughput process development screening, viral clearance validation studies, and scale down validation of chromatography processes. It also offers ELISA test kits; and chromatography resins under the CaptivA brand. In addition, the company provides filtration products, such as XCell Alternating Tangential Flow systems that are filtration devices used in upstream perfusion and cell culture processing; TangenX flat sheet cassettes, which are used in downstream biologic drug concentration, buffer exchange, and formulation processes; KrosFlo tangential flow filtration and tangential flow depth filtration systems; Spectra/Por laboratory and process dialysis products, and ProConnex TFDF flow paths. Further, it provides process analytics products, such as slope spectroscopy systems under the SoloVPE, FlowVPE, and FlowVPX brands. The company sells its products to life sciences, biopharmaceutical, and diagnostics companies; laboratory researchers; and contract manufacturing organizations. Repligen Corporation has collaboration agreements with Navigo Proteins GmbH to develop multiple affinity ligands. The company was incorporated in 1981 and is headquartered in Waltham, Massachusetts.